About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials in Miami | 257 Studies

Clinical Trials LymphomaMiami

Lymphoma Clinical Trials in Miami

Find 257 clinical trials for lymphoma near Miami, Florida. Connect with research centers in your area.

All Lymphoma trials nationwide All trials in Miami

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 257 trials

RecruitingA Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell LymphomaThe goal of this research study is to evaluate the combination of study drugs, Glofitamab and Polatuzumab, and a standard chemotherapy regimen, R-CHP, as a treatment for high-risk…NCT05800366·Miami, Florida and 2 others CompletedPXD101 in Treating Patients With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's LymphomaThis phase II trial is studying how well PXD101 works in treating patients with relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma.NCT00303953·Mobile, Alabama and 122 others

Lymphoma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedA Study in Participants With Moderate to Severe PsoriasisThe primary purpose for this study is to help answer the following research questions * The safety of ixekizumab (LY2439821) and any side effects that might be associated with it.NCT01107457·Bakersfield, California and 33 others

CompletedS1001 PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell LymphomaRATIONALE: Drugs used in chemotherapy, such as cyclophosphamide, doxorubicin hydrochloride, vincristine sulfate, and prednisone, work in different ways to stop cancer cells…NCT01359592·Anchorage, Alaska and 239 others

RecruitingDALY II USA/ MB-CART2019.1 for DLBCLDALY II USA is a phase II, multi-center, single arm study to evaluate the efficacy, safety, and pharmacokinetics of zamtocabtagene autoleucel (MB-CART2019.1) in patients with…NCT04792489·Birmingham, Alabama and 31 others

CompletedUse of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMCThis study is being done to understand how many people with HIV (PWH) present for cancer care across the AIDS Malignancy Consortium in the United States and if there are reasons…NCT05510908·La Jolla, California and 15 others

Active not recruitingEnsartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)This phase II Pediatric MATCH treatment trial studies how well ensartinib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with ALK or…NCT03213652·Birmingham, Alabama and 125 others

CompletedVemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)This phase II Pediatric MATCH trial studies how well vemurafenib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with BRAF V600…NCT03220035·Birmingham, Alabama and 115 others

RecruitingOpen-label of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Marginal Zone LymphomaThe purpose of this research study is to see if loncastuximab tesirine has any benefits at dose levels researchers found acceptable in earlier studies in patients with related…NCT05296070·Duarte, California and 3 others

Active not recruitingTalimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin CancersThis phase II trial studies how well talimogene laherparepvec and nivolumab work in treating patients with lymphomas that do not responded to treatment (refractory) or…NCT02978625·Los Angeles, California and 35 others

CompletedElectronic Health Mindfulness-based Music Therapy Intervention for Patients Undergoing Allogeneic Stem Cell TransplantationThe goal of this study is to pilot test an Electronic Health Mindfulness-based Music Therapy Intervention (eMBMT) intervention to improve health-related quality of life (HRQoL)…NCT05968963·Miami, Florida

TerminatedFirst-in-human Single Agent Study of SAR442257 in RRMM and RR-NHLPrimary Objective: To determine the maximum tolerated dose (MTD) of SAR442257 administered as a single agent in patients with relapsed and refractory multiple myeloma (RRMM) and…NCT04401020·Duarte, California and 15 others

CompletedAzacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene RearrangementThis pilot phase II trial studies the side effects of azacitidine and combination chemotherapy in infants with acute lymphoblastic leukemia and KMT2A gene rearrangement.NCT02828358·Birmingham, Alabama and 169 others

RecruitingA Master Protocol to Evaluate the Long-Term Safety of (LY3527727) PirtobrutinibThe master protocol study J2N-MC-JZNY provides a framework to enable the evaluation of the long-term safety and efficacy of pirtobrutinib after completion of clinical studies…NCT06876649·Jacksonville, Florida and 37 others

CompletedSamotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)This phase II Pediatric MATCH trial studies how well samotolisib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with TSC or PI3K/MTOR…NCT03213678·Birmingham, Alabama and 126 others

CompletedStudy Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin LymphomaThis study will be separated into 3 distinct phases designated as the Phase 1 study, Phase 2 pivotal study (Cohort 1 and Cohort 2), and Phase 2 safety management study (Cohort 3…NCT02348216·Gilbert, Arizona and 35 others

CompletedTraumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell TransplantationRATIONALE: Traumeel® S (a mouth rinse) may be effective in preventing or decreasing the severity of oral mucositis caused by chemotherapy in young patients who are undergoing stem…NCT00080873·Birmingham, Alabama and 43 others

CompletedDevelopment of Strategies to Increase Enrollment in Clinical Trials for Children With CancerRATIONALE: Taking part in a clinical trial may help children with cancer receive more effective treatment.NCT00002485·Sacramento, California and 30 others

RecruitingSoquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell LymphomaA Phase 3, randomized, 2-arm, open-label, multicenter, stratified study of soquelitinib versus physician's choice standard of care (SOC) treatment (selected single agents) in…NCT06561048·Duarte, California and 36 others

TerminatedVTX002 Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative ColitisThis is a study to understand if taking VTX002 daily as a tablet orally is safe and effective in participants diagnosed with moderate to severe ulcerative colitis (UC).NCT05156125·Garden Grove, California and 76 others

PreviousPage 2 of 13Next

Other Conditions in Miami

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia